سعر جاسموفاك 5 مجم 30 قرص 2024

Mosapride citrate 5 mg tablets (30), a 5-HT4 agonist prokinetic for upper GI symptoms; marketed in Egypt by Advocure.

• Gastrointestinal symptoms associated with chronic gastritis (heartburn, nausea and vomiting).Population: AdultsJAPIC / PMDA package insert (Sumitomo Pharma)
• Adjunct to oral bowel-cleansing solution in preparation for barium enema X-ray examination.Population: AdultsJAPIC / PMDA package insert (Sumitomo Pharma)

• Serious: fulminant hepatitis, liver dysfunction and jaundice (frequency unknown), with marked AST/ALT/GGT rises.International label, same formulation · JAPIC / PMDA package insert (Sumitomo Pharma)

• Fulminant hepatitis, serious liver dysfunction and jaundice may occur (deaths reported); do not give for long periods without need, and tell patients to stop and contact a doctor if fatigue, anorexia, dark urine or yellow eyes appear.International label, same formulation · JAPIC / PMDA package insert (Sumitomo Pharma)

• Anticholinergic drugs (e.g. atropine, butylscopolamine)May weaken the effect of mosapride (its prokinetic action depends on cholinergic activation); separate dosing times.JAPIC / PMDA package insert (Sumitomo Pharma)

• Use in pregnant women or women who may be pregnant only if the therapeutic benefit is judged to outweigh the risk.International label, same formulation · JAPIC / PMDA package insert (Sumitomo Pharma)
• Consider the benefits of treatment and of breastfeeding when deciding to continue or stop breastfeeding; transfer into milk was reported in rats.International label, same formulation · JAPIC / PMDA package insert (Sumitomo Pharma)

• Mosapride citrate: Selective 5-HT4 receptor agonist; stimulates acetylcholine release from the enteric plexus, promoting upper GI motility and gastric emptying (Japanese Gasmotin insert).